Exagen
XGN
XGN
34 hedge funds and large institutions have $19.8M invested in Exagen in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.59% more ownership
Funds ownership: 36.19% → 36.77% (+0.59%)
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
Holders
34
Holding in Top 10
–
Calls
$14K
Puts
$1K
Top Buyers
| 1 | +$543K | |
| 2 | +$287K | |
| 3 | +$251K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$110K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$49.5K |
Top Sellers
| 1 | -$841K | |
| 2 | -$106K | |
| 3 | -$31.4K | |
| 4 |
PM
Penbrook Management
New York
|
-$20.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$15.4K |